Opening book details…
About this Medicine article
Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation–Positive Non–Small Cell Lung Cancer in China by Cai, Hongfu; Zhang, Longfeng; Li, Na; Chen, Shen; Zheng, Bin; Yang, Jing; Weng, Lizhu; Liu, Mao-Bai is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Cai, Hongfu; Zhang, Longfeng; Li, Na; Chen, Shen; Zheng, Bin; Yang, Jing; Weng, Lizhu; Liu, Mao-Bai
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0149-2918)
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)